Antimicrobial resistance: moving forward to the past
Tore GH Liljeqvist A , David Andresen B , Yeqin Zuo C and Clare Weston C
+ Author Affiliations
- Author Affiliations
A NSW Public Health Officer Training Program, NSW Ministry of Health
B Children’s Hospital at Westmead and Concord Hospital
C National Prescribing Service (NPS); Better Choices Better Health
NSW Public Health Bulletin 23(2) 37-37 https://doi.org/10.1071/NB11043
Published: 28 March 2012
References
[1] Dr Margaret Chan. 6 April 2011 World Health Day. Available at: http://www.who.int/dg/speeches/2011/WHD_20110407/en/(Cited 12 October 2011).[2] Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, et al. British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008; 61 976–94.
| British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXksF2lt78%3D&md5=2f5829d08c753183c5b9591834a700ecCAS |
[3] Denholm JT, Huysmans M, Spelman D. Community acquisition of ESBL-producing Escherichia coli: a growing concern. Med J Aust 2009; 190 45–6.
[4] Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10 597–602.
| Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtVGqsrrP&md5=39f508894268466a633e7cd9b1698001CAS |
[5] Chhibber S, Kaur S, Kumari S. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 2008; 57 1508–13.
| Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.Crossref | GoogleScholarGoogle Scholar |
